Biomarkers in clinical trials: can we move from fortune telling to disease profiling?
- PMID: 21824932
- DOI: 10.1161/CIRCULATIONAHA.111.044271
Biomarkers in clinical trials: can we move from fortune telling to disease profiling?
Comment on
-
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Circulation. 2011 Aug 9;124(6):695-703. doi: 10.1161/CIRCULATIONAHA.110.014860. Epub 2011 Jul 18. Circulation. 2011. PMID: 21768545 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
